Table 1 The clinical characteristics of the two risk groups in TCGA
Characteristics | High_risk | Low_risk | P value |
|---|---|---|---|
Total number, N | 206 | 206 | Â |
Gender, n (%) | Â | Â | 0.9205 |
 Male | 120 (29.1%) | 119 (28.9%) |  |
 Female | 86 (20.9%) | 87 (21.1%) |  |
Age, n (%) |  |  |  < 0.001 |
 Age > 65 | 43 (10.4%) | 12 (2.9%) |  |
 Age ≤ 65 | 163 (39.6%) | 194 (47.1%) |  |
Treatment, n (%) | Â | Â | 0.6221 |
 Pharmaceutical therapy | 98 (23.8%) | 103 (25%) |  |
 Radiation therapy | 108 (26.2%) | 103 (25%) |  |
Project, n (%) |  |  |  < 0.001 |
 TCGA-GBM | 142 (34.5%) | 78 (18.9%) |  |
 TCGA-LGG | 64 (15.5%) | 128 (31.1%) |  |